NasdaqCM - Nasdaq Real Time Price USD

SeaStar Medical Holding Corporation (ICU)

Compare
3.2300 -0.0300 (-0.92%)
As of 10:07 AM EDT. Market Open.
Loading Chart for ICU
DELL
  • Previous Close 3.2600
  • Open 3.2700
  • Bid 3.1700 x 300
  • Ask 3.3000 x 300
  • Day's Range 3.2300 - 3.3899
  • 52 Week Range 3.2300 - 42.9250
  • Volume 22,384
  • Avg. Volume 75,243
  • Market Cap (intraday) 13.539M
  • Beta (5Y Monthly) -1.11
  • PE Ratio (TTM) --
  • EPS (TTM) -18.5500
  • Earnings Date Nov 12, 2024 - Nov 18, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 18.00

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

www.seastarmedical.com

12

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ICU

View More

Performance Overview: ICU

Trailing total returns as of 10/31/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ICU
70.84%
S&P 500
20.53%

1-Year Return

ICU
87.08%
S&P 500
37.97%

3-Year Return

ICU
98.71%
S&P 500
24.83%

5-Year Return

ICU
98.68%
S&P 500
46.83%

Compare To: ICU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ICU

View More

Valuation Measures

Annual
As of 10/30/2024
  • Market Cap

    13.75M

  • Enterprise Value

    15.71M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -308.09%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -32.62M

  • Diluted EPS (ttm)

    -18.5500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.18M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -5.69M

Research Analysis: ICU

View More

Earnings Per Share

Consensus EPS
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

18.00
18.00 Average
3.2300 Current
18.00 High
 

Company Insights: ICU

People Also Watch